Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01869790 · ClinicalTrials.gov registry record · NA

Evaluation of Fats on Postprandial Glucose Control

A NA study, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01869790: Completed NA study, sponsored by Joslin Diabetes Center.

NCT01869790 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01869790, a NA study, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is examine the effect of different fat types on postprandial glucose control in patients with type 1 diabetes. Subjects will have several admissions and, in random order, will receive lunches with identical carbohydrate content but different fat content: lunch A will minimal fat content, lunch B will contain added butter, lunch C will contain added olive oil, and lunch D will contain added cheese. Total fat content in lunches B-D will be the same. Subjects will receive identical insulin doses (calculated using the subject's usual insulin-to-carbohydrate ratio) for the meals. The investigators hypothesize that, despite identical carbohydrate content,the lunches higher in saturated fat will lead to more postprandial hyperglycemia than the lunch containing minimal fat and the lunch high in monounsaturated fat. The hypothesis is that from time points 0-180 minute area under the curve for Lunches A, B, C, and D will be the same, whereas from time points 180-360 minutes for Lunch B and D will be greater than that of Lunch A and C.

Primary Outcome

One-way repeated measures ANOVA will be used to analyze area under curve differences between the three lunches as well as time in target range (80-180 mg/dL), peak blood glucose, time to peak blood glucose, time to return to baseline blood glucose.

Interventions

  • OTHER Different fat types

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-06
Est. Completion 2015-04
Phase NA
Joslin Diabetes Center

73 total trials

What the finished NCT01869790 record still lists

NCT01869790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Different fat types is the first listed.

NCT01869790 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01869790 about?

NCT01869790 is a clinical study titled "Evaluation of Fats on Postprandial Glucose Control". The purpose of this study is examine the effect of different fat types on postprandial glucose control in patients with type 1 diabetes. Subjects will have several admissions and, in random order, will receive lunches with identical carbohydrate content but different fat content: lunch A will minim...

What is the current status of trial NCT01869790?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2013-06. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01869790?

The interventions under investigation include: Different fat types (OTHER).

Who is sponsoring clinical trial NCT01869790?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01869790's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01869790, the US trial registry maintained by the National Library of Medicine. NCT01869790 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.